Navigation Links
Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East
Date:11/20/2009

HAIFA, Israel, November 20 /PRNewswire-FirstCall/ -- Cardio Vascular Medical Device Corp. (CVSL.OB), http://www.CVSLMEDICAL.COM, a leading developer of advanced cardiovascular surgery technology, today announced that the company's Board of Directors has decided to initiate patent applications in Europe, Canada and the Far East for its proprietary next-generation "steerable guidewire" applicable for all angioplasty (PCTA) procedures.

Cardio Vascular Medical Device already holds a US patent for the innovative guidewire. The company has elected to apply for the additional patents in order to penetrate a worldwide commercial marketplace for the life-saving angioplasty procedure.

Angioplasty is a common procedure that is performed to widen narrowed or obstructed blood vessels. The procedure is often performed in place of, or before a more invasive and potentially life-threatening bypass surgery is needed. Angioplasty that is performed before an artery is fully-blocked can prevent the onset of heart attacks.

More than seven million angioplasties are performed worldwide each year. The potential addressable market for angioplasty equipment exceeds $500 million.

According to the World Health Organization, some 7.2 million men and women die as a result of cardiac heart disease. Heart disease is the leading cause of death for both women and men in the United States.

"Filing these additional patent applications is the first stage in aiding cardiologists in the process of saving lives across the globe," stated Eli Gonen, CEO of Cardio Vascular Medical Device Corp.

"The ability to steer our guidewire during angioplasty procedures using our patented flexi-tip enables more difficult procedures to be completed with greater ease, and speeds overall procedure time," Gonen added. "Due to these significant advantages, Cardio Vascular Medical Device's guidewire has the opportunity to become the guidewire of choice for surgeons throughout the world."

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Cardio Vascular Medical Device Corp. and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated in the forward-looking statements. Cardio Vascular Medical Device Corp. public filings may be viewed at www.sec.gov.

    Contact:

    Alex Traiman
    Media Relations
    +1-646-863-9729

    Asher Zwebner
    +972-54-464-6363
    asher@fxmng.com


SOURCE Cardio Vascular Medicine Device Corp.


'/>"/>
SOURCE Cardio Vascular Medicine Device Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
3. Pot bellies linked to early signs of cardiovascular disease
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. Environmental stress probed in cardiovascular disease, diabetes
6. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
7. Cardiome to Present at Bear Stearns Conference
8. SCAI and ACC announce new interventional cardiology meeting
9. American Heart Association Enhances eLearning for Emergency Cardiovascular Care (ECC)
10. Cardiome to Present at ThinkEquity Conference
11. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Tuesday, May 24, Women's Excellence ... practice enhanced with Young Living Essential Oils, taught by Patti Dolan, RYT, a ... Orion location. Yoga Flow is 6:30pm - 7:15pm followed by a small intro to ...
(Date:5/24/2016)... ... ... launched the #perioddrama campaign to mark Menstrual Hygiene Day on May 28 and raise ... do not have access to a toilet, even when they’re on their periods. , WaterAid ... (sometimes hilarious) results help shine a light on the awkwardness that women face while menstruating, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Local ... Republic on September 21, 2016. Dr. Gerard, who holds a Doctorate of Chiropractic ... not-for-profit organization promoting health and wellness in Third World countries where resources are ...
(Date:5/24/2016)... ... ... The Dream Builders Project, a 501(c)3 nonprofit organization based in Los Angeles, ... Mexico on Saturday, May 21st. The volunteers took the children out for the day ... 15 volunteers traveled from Los Angeles to Tijuana, Mexico for the day in the ...
(Date:5/24/2016)... , ... May 24, 2016 , ... The old expression ... the problem. A common injury that’s often misunderstood, whiplash should be swiftly diagnosed and ... Harvard-trained, orthopedic spine surgeon at Atlantic Spine Center . , So named ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... May 23, 2016 Global Paclitaxel ... pages, profiles 12 companies and the Paclitaxel analysis in ... on the industry and its players. This ... in nature, details the current state of the industry ... definitions, classifications, applications and industry chain structure. The Paclitaxel ...
(Date:5/23/2016)... May 23, 2016 The World Health Organization (WHO) ... device to include adolescents aged 13 years, and above. Effective ... offered for adult and adolescent males in the 14 priority ... PrePex was the first male circumcision device to receive WHO ... Eddy Horowitz said: " The expanded ...
(Date:5/23/2016)... May 23, 2016   Purdue Pharma L.P. ... an agreement with Egalet Corporation and Acura Pharmaceuticals, ... part of the agreement the companies will exchange ... all three companies to develop and sell several ... "This agreement reflects the commitment of Purdue Pharma ...
Breaking Medicine Technology: